Sector: MedicalCell Genesys, Inc. (NASDAQ: CEGE)
Headlines
- BioSante Pharmaceuticals and Cell Genesys Announce Completion of Merger
Oct 14, 2009 01:17 PM | BPAX, CEGE
- Marc J. Fagel of the U.S. Securities and Exchange Commission to Discuss SEC Enforcement at CBI's Biotech/Pharma Finance and Accounting Forum in San Francisco
Oct 07, 2009 07:35 AM | CEGE, PARD
- Pre-Market: Health Care Shares Mixed in Pre-Market Session - BioSante Pharma Shareholders OK Cell Genesys Merger
Oct 01, 2009 09:20 AM | BPAX, CEGE, CTIC, HALO, RVSN, VICL
- BioSante (NASDAQ: BPAX): LibiGel Provides Big Upside Potential
Sep 27, 2009 02:40 PM | BPAX, CEGE, TEVA, VVUS
- RiskMetrics Group - ISS Governance Services Recommends Stockholders Vote "FOR" BioSante and Cell Genesys Merger
Sep 17, 2009 07:00 AM | BPAX, CEGE, RMG
- BioSante Pharmaceuticals and Cell Genesys Announce September 30, 2009 Special Stockholders Meetings to Approve Merger
Sep 03, 2009 08:00 AM | BPAX, CEGE
- BioSante Pharmaceuticals to Present at Upcoming Healthcare Conferences
Sep 02, 2009 05:03 PM | BPAX, CEGE
- OTC Select Announces NASDAQ Daily Stock Watch - ACAD, AKNS, CEGE, CSKI, DYAX
Jun 10, 2009 08:01 AM | ACAD, AKNS, CEGE, CSKI, DYAX
- Hope The Lows Will Hold
Oct 16, 2008 09:48 AM | ABK, ACGY, ACI, AIG, BAX, BCS
- NASDAQ Technical Picture - Expansion
May 02, 2008 02:01 AM | ABAX, ACAP, ACS, AMSF, AVNX, BEBE
- Movers: Google, Citigroup, eBay, Yahoo, Peabody Energy
Oct 17, 2008 10:53 AM | AOS, BGG, BTU, C, CAL, CEGE
- BioSante Pharmaceuticals and Cell Genesys Announce Approval of Merger By BioSante Stockholders and Adjournment of Cell Genesys Stockholders Meeting Until October 14, 2009
Sep 30, 2009 04:53 PM | BPAX, CEGE
- PicksThatMove.Com Announces Investment Opinion: Risk and Reward on Momentum Investing
Sep 23, 2009 11:12 AM | CEGE, KERX, OPXA, QTWW, WAVE
- BioSante Pharmaceuticals and Cell Genesys Announce Final Exchange Ratio for Merger
Sep 22, 2009 06:51 PM | BPAX, CEGE
- BioSante Pharmaceuticals Reports Second Quarter 2009 Financial Results
Aug 07, 2009 05:56 PM | BPAX, CEGE
- Ceregene Receives Additional Grant From Michael J. Fox Foundation to Expand Long-Term Testing of CERE-120 Patients
Aug 05, 2009 09:02 AM | CEGE, GENZ
- Cell Genesys Announces Second Quarter 2009 Financial Results
Aug 05, 2009 06:03 AM | CEGE
- BioSante Pharmaceuticals and Cell Genesys Sign Definitive Merger Agreement
Jun 30, 2009 08:28 AM | BPAX, CEGE
- RothmanResearch.Com Stock Review for MCHP, EMKR, CEGE, APWR , MSFT and INTC
Jun 24, 2009 09:22 AM | APWR, CEGE, EMKR, INTC, MCHP, MSFT
- Cell Genesys Announces Tender Offer Results While Continuing to Pursue Strategic Alternatives
Jun 23, 2009 07:31 AM | CEGE
- Ceregene Presents Additional Clinical Data from Phase 2 Trial of CERE-120 for Parkinson's Disease
May 27, 2009 08:13 AM | CEGE, GENZ
- Form 4 Kopp LeRoy C For: Oct 14 (10K)
Oct 27, 2009 08:21 PM
- Form 4 SHERWIN STEPHEN A For: Oct 14 (10K)
Oct 15, 2009 07:30 PM
- Form 4 POTTS JOHN T JR For: Oct 14 (10K)
Oct 15, 2009 07:08 PM
- Form 4 TIDWELL ROBERT H For: Oct 14 (10K)
Oct 15, 2009 07:03 PM
- Form 4 WINGER DENNIS L For: Oct 14 (10K)
Oct 15, 2009 06:38 PM
- Form 4 Belsky Marc For: Oct 14 (10K)
Oct 15, 2009 06:37 PM
- Form 4 STEP EUGENE L For: Oct 14 (10K)
Oct 15, 2009 06:28 PM
- Form 4 TETLOW SHARON For: Oct 14 (10K)
Oct 15, 2009 06:23 PM
- Form 4 VERMA INDER M For: Oct 14 (10K)
Oct 15, 2009 05:44 PM
- Form 4 GOWER JAMES M For: Oct 14 (10K)
Oct 15, 2009 05:15 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
CEGE
|
Compare to S&P
|
| YTD |
46.50 %
|
17.21 %
|
| 4 Weeks |
-4.08 %
|
-5.92 %
|
| 12 Weeks |
40.01 %
|
24.53 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -14.29 %
|
|
EPS Growth in Last Year: -14.29 %
|
|
Sales Growth in Last Quarter: -98.52 %
|
|
Sales Growth in Last Quarter: -94.78 %
|
|
